Dr. Assimos named first chair of urology at Alabama
Dean G. Assimos, MD, has been named the inaugural chair of the department of urology in the University of Alabama at Birmingham School of Medicine.
Dean G. Assimos, MD, has been named the inaugural chair of the department of urology in the University of Alabama at Birmingham School of Medicine.
Dr. Assimos was previously vice chair of urology at Wake Forest University, Winston-Salem, NC. He received his medical degree from the Loyola Stritch School of Medicine in Chicago. He completed a 6-year urology residency at Northwestern University, Chicago, in 1983, and a fellowship in renal reconstructive surgery and stone disease at Wake Forest University the following year. He served as an AUA research scholar from 1984 to 1986.
Previously a division within the department of surgery at the University of Alabama, the department of urology was created by the UAB Board of Trustees in April 2012.
"My goals and vision for the department of urology at UAB include developing a program that is regionally, nationally, and internationally recognized for providing excellent patient care in all domains of urology," Dr. Assimos said. "We will cultivate a stimulating educational environment for medical students, graduate students, residents, fellows, and post-docs, as well as practicing urologists and the public."
Dr. Assimos has been actively involved in the establishment of practice guidelines in urology. He is on the editorial board of the Journal of Endourology, serves on the editorial council of Urology Times, and contributes to the urologic survey section of the Journal of Urology. He is a National Institutes of Health-funded physician scientist whose research has focused on endogenous oxalate synthesis of and the role of dietary oxalate in kidney stone formation.
Dr. Assimos’ clinical practice is concentrated on the surgical management of patients with complex calculous disease, ureteral reconstruction, and metabolic stone evaluation and treatment.
Go back to this issue of Urology Times eNews.
Related Content
Dr. Jayanthi appointed urology chief at Nationwide Children's Hospital
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
